Search - tctmd.com

Displaying 1 - 20 of 48

Sort: Relevancy | Date

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

Michael O'Riordan

October 02, 2025

News Daily News

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Todd Neale

July 16, 2025

News Daily News

Cardiotoxicity Rare With Common GI Chemotherapy

L.A. McKeown

April 15, 2025

News Daily News

Aspirin Use for Primary Prevention Declining in US: NHANES

Michael O'Riordan

January 24, 2025

News Daily News

Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review

Todd Neale

January 09, 2025

News Daily News

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

L.A. McKeown

June 18, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Daily News

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

Yael L. Maxwell

October 19, 2023

News Daily News

Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study

L.A. McKeown

October 10, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Daily News

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Michael O'Riordan

February 16, 2023

News Daily News

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

L.A. McKeown

February 13, 2023

News Daily News

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

L.A. McKeown

January 13, 2023

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Daily News

Acute MI, Stroke Risks Rise in the Months After Gout Flares

Todd Neale

August 02, 2022

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Daily News

CV Risk Factor Control Cuts Post-op Nursing Home Transfer for Black Americans

Yael L. Maxwell

July 22, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Yael L. Maxwell

June 23, 2022

Advertisement

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Risk Factors Present in Nearly All Patients Who Develop CVD

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Cardiotoxicity Rare With Common GI Chemotherapy

Aspirin Use for Primary Prevention Declining in US: NHANES

Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Acute MI, Stroke Risks Rise in the Months After Gout Flares

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

CV Risk Factor Control Cuts Post-op Nursing Home Transfer for Black Americans

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content